Baidu
map

10大新变局正深刻影响中国医疗界!

2017-10-05 周伯通 “看医界”微信号

十大新变局机遇和挑战并存,与医生朋友们息息相关。

十大新变局机遇和挑战并存,与医生朋友们息息相关。

一、医学将回归精英教育:花样学制将逐步被统一!

在7年制退出历史舞台之后,前不久,中国医学教育又迎来重大改革,国务院办公厅公布《关于深化医教协同进一步推进医学教育改革与发展的意见》,明确要求严格控制医学院校本科临床医学类专业单点招生规模。并严控8年制招生数量。

医学院招生数量将被缩紧,这将意味着医学院大扩招时代将一去不复返;不仅如此, 中专、大专临床医学专业也有望退出历史舞台,初中毕业学医的中国式尴尬将逐步成为历史。

未来,5年的本科教育加上3年的住院医生规范化培训,再加专科医师规范化培训将成为中国医学教育的主流,八年一贯制临床博士培养数量不仅将被紧缩,也将黯然失色。

其中,在住院医规培期间,有望实现规培医生的社会人身份,即规培完了再找工作。

这一系列改革将意味着学医的时间成本大大提高,医学教育改革朝着精英化方向发展。

对此,一位资深医学教育专家表示,医学必须是精英教育,但也应该是精英待遇,二者缺一不可,否则将很难吸引优秀人才学医,从医。

二、大批内科医生被逼走向市场!

据《看医界》获悉,上海一家知名三甲医院某内科专科患者一年竟然下降了四分之一。事实上,据了解,随着取消药品加成改革的推进,内科正在成为公立医院的包袱,一位院长甚至直言,内科现在是看一个亏一个。

当内科不再是公立医院的创收科室,内科医生的前途开始堪忧,再加上分级诊疗改革的推进,一些三级医院内科将面临着一方面缺患者,另一方面患者来了又亏钱的窘境。

如此一来,内科医生迫于生计将不得不自寻出路。

据上海SIMC院长黄翼然近日介绍,该院就是借助公立三甲医院内科医生走向市场的机遇,吸引了一批内科医生到医院坐诊,还因此吸引了一批内科患者前来就诊,医院门诊量翻倍增长。

此外,内科医生开诊所也将是一大趋势,反过来也将大大推进分级诊疗制度的建设进程。

三、中国医疗正在迎来体验革命!

这一变局尤为重要,因此,伯通用了“革命”二字。

据了解,一些医疗界人士不承认医疗是服务业,担心把医生等同于“服务员”。事实上,不管如何强调医疗的特殊性,医护提供的是医疗服务这一点无法改变。

对此,一位业内人士直言,是否承认医疗为服务业,是医生自由执业的前提;并直言,中国医疗将迎来体验革命。

啥是体验革命呢?众所周知,长期以来,中国人看病叫求医,公立医院人山人海,患者体验差,医患矛盾不断。但随着经济的发展、民众收入水平的提高,过去能够将就的糟糕体验很难再将就下去,整个医疗界的服务升级在患者体验方面必将迎来一次革命。

首先,在大批涌现的社会办医院领域,和公立医院主要竞争什么?技术?恐怕短时间内还很难,但在服务体验方面大有可为,完全可以由此实现弯道超车。

不仅如此,据了解,走向市场的医生,一般都非常重视患者体验,在医疗服务的患者体验上可谓精益求精。一家医生集团甚至打出了“不允许患者不满意”的口号。不是说强迫患者满意,而是一定要找到患者不够满意的地方,改进服务后让患者满意。

可以预见的是,随着社会办医的快速发展,大批医生走向市场,中国医疗界正在迎来一场医疗服务的体验革命,在这一进程中将实现多方受益,还必将倒逼公立医院服务体验改革。

四、医疗反腐风暴愈演愈烈!

众所周知,药品价格虚高是畸形的“以药养医”医药卫生体制造成的,导致要靠灰色收入来保障医生职业的吸引力,这一制度也是导致中国医生群体被污名化的重要原因之一,甚至还导致不少院长、科主任及普通医生被查甚至入狱。

一位知名三甲医院科主任甚至直言:“感谢行业潜规则,不然没人做医生。”

但是很显然,这一畸形的格局到了需要被打破的时候。据《看医界》了解,医疗反腐从未停歇,但很明显近几年风暴愈演愈烈。别说院长,就连落马科主任的数量似乎数都数不清,而且牵出不少窝案,整科室的医生被查,安徽滁州甚至还发生了一县医院大多数医生被查的事件。

对此,业内人士表示,取消“以药养医”绝不是简单地取消医院层面的药品加成,在持续提高医技性服务价格、医生阳光收入的大趋势下,大幅压缩药品回扣环节,打击医疗腐败势在必行,一些回扣重点科室正在成为医疗反腐重灾区。

五、大批公立医院将被托管、改制、降级!

前段时间,山西太原被爆出三家三甲医院主动按照二级医院标准收费的消息,引起业内哗然,甚至被部分媒体解读为“医院自降等级”。

事实上,这样的医院被改制或“降级”是大趋势。用北京卫计委党委书记方来英的话说,中国根本不需要这么多三级医院。再说这些医院根本达不到三级医院本应承担的科教研及临床为一体的责任,本身活着都困难。因此,随着医学中心建设大潮的到来,一些类似名不副实的三级医院将面临托管、改制、降级等命运。

不仅如此,一些大中城市二级医院也基本上是上述命运,被大医院托管或被改制将成为大概率事件。

值得关注的是,在县级医院领域,一些药企正在发起凌厉的托管、改制攻势,能改制的改制,不同意改制的就合作建新院,再不济就托管。

六、百万医生大流动:共享医生时代来了!

医生资源具有典型的共享经济属性,即使是在绝大多数医生被困在体制内的情况下,飞刀、走穴从未停止过,因此被开玩笑说,一到周末,机场形形色色的人流中,飞刀医生一抓一把。

但据《看医界》了解,长期以来,中国的医院,无论公立还是私立,都对优质医生资源形成了根深蒂固的占有欲,非要挖过来独享才罢休。

然而随着政策的持续解放,医生大流动的到来,独享优质医生资源越来越困难,越来越不现实。

可行的出路,就是共享优质医生资源,让医生自由执业。医生可以在多家医院执业,还可以自己开医院、办诊所。

对此,业内人士表示,共享医生,将极大地提高优质医生资源的使用效率,解决优质医生资源配置不均衡的难题。

七、私立医院平台化时代来了

既然要实现共享医生,私立医院平台化就是必然趋势。

据了解,在一些医生自由执业的欧美国家,医院和医生的关系就好比舞台和舞者,舞台就是医院,舞者就是医生,医院为医生提供执业舞台,医生可以在多个舞台“演出”。

遗憾的是,据悉目前不少私立医院的院长、老板对于医生多点执业、自由执业并不热情,甚至对于医生集团心怀敌意。

以一位三甲私立医院老板为例,一方面担心多点执业医生不负责任,出了事拍屁股走人,另一方面也担心医生集团未来也办医院,等于培养了竞争对手。

对此,业内人士表示,上海的公立医院都能够成为医生集团及医生团队多点执业的舞台,一些还没有醒过神来的私立医院真应该好好反思了,否则将错过非常好的发展机遇。

八、患者看病认“和尚”时代来了! 医生品牌至关重要

长期以来,中国患者看病都是认庙不认和尚,打听哪家医院好,打听到了直接找这家医院的科主任,准没错。

以至于和学挖掘机一样,都知道蓝翔技校不错,但具体是哪位师傅教的好,没人答得上来。

但据《看医界》了解,随着市场经济逐步深入医疗领域,中国医生的品牌意识开始觉醒,无论是体制内还是体制外的医生,都越来越重视个人品牌的建设,力图通过互联网、社交媒体等途径拓展品牌影响力;患者也不再满足于到了医院被随机分配医生的服务,开始主动寻求品牌医生提供服务。

可以预见的是,在解放医生的大潮下,中国医生品牌将迎来大洗牌,一批在患者心目中的全国医生品牌及区域医生品牌将脱颖而出,越来越多的患者将奔着医生的品牌联系就医。

而一旦拥有了品牌和患者流量,将极大地促进医生的解放进程。

九、医生创业潮来袭,医生企业家批量出现!

在解放医生的大潮中,政策上鼓励医生办医是一大趋势,无论是开诊所还是办医院、医生集团,无论是兼职创业还是全职创业都可以。

据《看医界》了解,越来越多的医生正在创办诊所、医院、医生集团,从纯粹的医生身份向企业运营管理者的身份转变。

不仅如此,在互联网时代,借助互联网平台创业也是一大趋势,一些已经获得一定线上流量的医生纷纷转型创办医疗健康咨询平台。

在这一进程中,不仅将创造巨大的社会价值和市场价值,极大地推进医疗健康产业的发展,还将催生一批医生企业家,而且身价不菲。

十、人工智能将取代一批医生!

马云曾经夸下海口说让医生失业,在医疗界引起巨大争议。其实说的就是人工智能。那么,人工智能究竟会不会取代医生?答案是,不可能完全取代,但会取代一部分医生。

那么哪一部分医生会被取代呢?用春田医管创始人、上海一妇婴原院长段涛教授的话来说,一些低于平均水平的医生将被人工智能取代。

《看医界》今年曾受邀参加阿里巴巴在深圳开的一场互联网大会,其中就展示了一些加入阿里云人工智能的医生团队的科研成果,对于一些疾病的智能诊断准确率堪比专家。可见马云绝不仅仅是说说而已。

段涛表示,“如果把全球所有皮肤科的疾病都整理好、对应好,只要把患者患处的照片发过去,人工智能就告诉你这是什么,而且诊断比我们绝大多数的皮肤科医生都要准确,都要及时。还需要那么多皮肤科医生吗?”

除此之外,病理科、影像科等一批科室都将受到人工智能的巨大冲击。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-10 1e207054m17(暂无匿称)

    有用吗?不乐观

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-07 三生有幸9135

    学习一下谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-06 涵涵

    未来的挑战极大!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-06 涵涵

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-06 1e0e5697m83(暂无匿称)

    henhao

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-06 lyh994

    这么多的趋势潮流

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-06 惠映实验室

    学习了.谢谢.

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1722769, encodeId=dc821e2276940, content=<a href='/topic/show?id=95a821e42a1' target=_blank style='color:#2F92EE;'>#中国医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21742, encryptionId=95a821e42a1, topicName=中国医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f33313955, createdName=charleshjw, createdTime=Fri Jun 08 23:44:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251641, encodeId=8a5d2516413d, content=有用吗?不乐观, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Tue Oct 10 04:45:19 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374550, encodeId=9a7813e45500d, content=<a href='/topic/show?id=1aed3509902' target=_blank style='color:#2F92EE;'>#医疗界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35099, encryptionId=1aed3509902, topicName=医疗界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ca5383, createdName=bbjsj_1979, createdTime=Sat Oct 07 14:44:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251071, encodeId=735f2510e10d, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Sat Oct 07 10:49:58 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250830, encodeId=f36e2508304b, content=未来的挑战极大!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:57:26 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250829, encodeId=934525082948, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=677e1645567, createdName=涵涵, createdTime=Fri Oct 06 14:56:51 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250816, encodeId=8cd3250816c6, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Fri Oct 06 14:12:46 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250763, encodeId=f38a250e6312, content=这么多的趋势潮流, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Oct 06 09:35:39 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250733, encodeId=18c4250e3321, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Oct 06 08:20:22 CST 2017, time=2017-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=250717, encodeId=994b250e1753, content=好好的看下.有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Oct 06 07:43:20 CST 2017, time=2017-10-06, status=1, ipAttribution=)]
    2017-10-06 忠诚向上

    好好的看下.有用

    0

相关资讯

医保经办人员的大智慧! ——取消医保定点行政审批之后

大家还记得吗?2015年10月,国务院决定取消的第一批62项中央制定、地方实施的行政审批事项中,就包括取消“基本医疗保险定点医疗机构和定点零售药店”的资格审批。但是,医保经办管理部门的担子可一点也不轻啊!相反,由于管理方式转变、改革政策性强、社会关注度高等特点,更需要医保人精细化管理,严格监督。在这个转变中,成都市医保局在建立协议管理制度、完善协议文本、创新医保协议监管方面下了不少功夫,结出累累创

药品监管改革的大刀将挥向何方?

自2015年国务院发布了44号文之后,医药监管改革的举措令人应接不暇,其改革的速度之快和力度之大令人惊叹 。行业内一些研发、生产、销售的乱象得到了强有力的整治,也提高了社会对于药品质量提升的信心。但是总局一系列的改革组合拳,也让我们的制药企业疲于应对,真是“一波还未平息,一波又来侵袭”。

盘点这10年CFDA为“孤儿药”做出的一系列改革

孤儿药的研究热情曾一度受“低发病率”“投资回报率”“研发难度大”、“适用患者少”等因素影响,不少制药企业也因此不愿涉足该领域。现在,随着社会认知度提高、支持政策出台、诊断及治疗手段增多,罕见病药物开发风向正在转暖。在“第十二届国际罕见病与孤儿药大会暨第六届中国罕见病高峰论坛”上,来自于国家食品药品监督管理总局药品审评中心的生物制品临床部部长高晨燕和化药临床一步高级审评员张杰从国家政策层面跟大家

破除旧模式 “人性化”的护理管理模式如何开展?

在医院护理管理的基础上,某医院在病房管理中开展了人性化护理的模式,取得了较好的效益,现总结如下。1.存在的护理问题1.1护理操作不到位当年轻护士给婴幼儿静脉注射、抽血等治疗时,有时需再次操作,家长不能正确理解,还有因为静脉穿刺失败等操作不到位引起纠纷。1.2与患者及其家属沟通不够艺术对新入院患者,因其对住院环境、制度等都很陌生,这时应对其重点介绍一些实际问题,有的护士询问患者病情时态度生硬;还有的

邓小虹:医保支付方式改革不仅仅为了控费

医保支付方式改革是为了控制医疗费用,这是大多数人对医保支付方式改革的第一反应。医保支付方式改革真的仅仅是为了控费?在近日召开的2017中华医院信息网络大会(2017 CHINC)上,国务院参事、国家卫计委医政医管局DRG质控中心主任邓小虹介绍了医保支付方式改革、DRG的来龙去脉,以及背后的思路。为何要改医保支付方式邓小虹表示,目前新医改五大任务里最重要、最有成效的要数建立了覆盖全民的社会医疗保

医院评审要与时俱进

4年一次的医院等级评审就像“大考”,因其重要性和与医院利益的切实相关性,一举一动始终牵动行业目光。不论对医院评审本身有多少争议和探讨,都不能否定这一外部评价对医院内部提升的促进意义。评审不是不需要,而是需要与时俱进。

Baidu
map
Baidu
map
Baidu
map